SILVER SPRING, Md.,
March 8, 2012 /PRNewswire/ -- Sunpeaks Ventures,
Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or
"Sunpeaks Ventures") and its wholly owned subsidiary Healthcare
Distribution Specialist, LLC ("HDS") are pleased to announce that
they have entered into the final stages of negotiations to engage a
well-known sports celebrity to act as Clotamin® national
spokesperson. Clotamin is the world's first specialized OTC
multivitamin product designed exclusively for use by patients on
Warfarin® and other anticoagulants (blood thinners).
The proposed sports celebrity spokesperson is a current National
Basketball Association (NBA) head coach and Naismith Basketball
Hall of Fame nominated player. During his 15+ year career as
a player in the NBA, he collected more than 10,000 points and
10,000 rebounds, won three championship rings, and was twice named
to the NBA All-Star team. He is listed in the NBA Top 20 List
for career games played, career rebounding leaders, and career
playoff rebounding leaders. Since his retirement from active
play, he has spent time as a popular NBA television commentator and
as head coach with several NBA teams.
"We couldn't be happier about identifying a current Clotamin
user who also happens to be a legendary player and coach in the
NBA. We believe that a strong marketing campaign featuring
this individual could really help to boost Clotamin awareness and
sales across the board," stated Mackie A.
Barch, CEO of Sunpeaks. "Upon successful conclusion of
negotiations, we intend to launch a national ad campaign featuring
the famous player/coach designed to drive Clotamin into new markets
and distribution channels."
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary
Healthcare Distribution Specialists, LLC ("HDS"), is a nationally
focused, value-added distributor of specialty drugs and
over-the-counter ("OTC") branded multivitamins to the healthcare
provider market. HDS also owns and markets Clotamin®, a
specialized over-the-counter multivitamin product designed
exclusively for use by patients also on Warfarin®, a popular blood
thinner that has a long list of known adverse drug and food
interactions.
For additional information, please visit
www.sunpeaksventures.com.
Safe Harbor Statement
Information in this document constitute forward-looking
statements or statements which may be deemed or construed to be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The words
"forecast", "anticipate", "estimate", "project", "intend",
"expect", "should", "believe", and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to known and unknown risks,
uncertainties and other factors which could cause Sunpeaks
Ventures' actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and
other factors are more fully discussed in Sunpeaks Ventures'
filings with the U.S. Securities and Exchange Commission. All
forward-looking statements attributable to Sunpeaks Ventures herein
are expressly qualified in their entirety by the above-mentioned
cautionary statement. Sunpeaks Ventures disclaims any
obligation to update forward-looking statements contained in this
estimate, except as may be required by law.
Contact: Financial Insights 888-248-8491 or
info@sunpeaksventures.com
SOURCE Sunpeaks Ventures, Inc.